IF a dual-vector allotopic rescue system — comprising (i) AAV2 (intravitreal, ~1×10¹⁰ vg/eye) delivering a codon-recoded, mitochondrial targeting sequence (MTS)-fused MT-ND4 allotope modeled on the lenadogene nolparvovec/GS010 construct, and (ii) AAV9 (systemic intravenous, ~2×10¹³ vg/kg) delivering the identical nuclear-encoded ND4 cassette — is administered to aged (24-month-old), male and female C57BL/6J mice harboring a mosaic burden of somatic ND4/Complex I mtDNA mutations,
THEN a ≥30% rescue of mitochondrial Complex I–linked oxygen consumption rate (OCR) will be observed in both retinal ganglion cells (RGCs) and skeletal muscle fibers within 16 weeks post-injection, accompanied by ≥20% preservation of surviving RGC density (OCT/RBPMS immunostaining), ≥15% improvement in rotarod endurance, and a measurable reduction in the fraction of cells exhibiting Complete I enzyme histochemistry (COX/SDH) dropout to levels approaching those of 6-month-old reference animals,
BECAUSE the following causal chain connects intervention to outcome:
- Aged post-mitotic cells accumulate somatic ND4 point mutations and large-scale mtDNA deletions through clonal expansion, creating heteroplasmic mosaic dysfunction within individual RGCs and skeletal muscle fibers where Complex I assembly and electron flux are compromised once heteroplasmy crosses the tissue-specific biochemical threshold for OXPHOS failure. (Evidence Set: Literature Task Output — "mtDNA is indispensable for the generation of cellular ATP… close physical proximity to the electron transport chain — the primary intracel





























